Investigating how immune cells present antigens in the brains of Alzheimer's patients
Microglia antigen presentation in the CNS of Alzheimer's disease
This study is looking at how certain immune cells in the brain, called microglia, might affect the progression of Alzheimer's disease by examining brain and blood samples from patients, and it aims to uncover new information that could help us understand the disease better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10800644 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of microglia, the immune cells in the brain, in Alzheimer's disease. By examining brain tissue and blood samples from Alzheimer's patients, the researchers aim to identify specific antigens that microglia present to T cells, which may contribute to the disease's progression. The study employs advanced technologies to analyze these interactions in different regions of the brain, particularly where T cell activity is high or low. This multifaceted approach could reveal new insights into the immune mechanisms involved in Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease, particularly those in the later stages of the condition.
Not a fit: Patients with early-stage Alzheimer's or other forms of dementia unrelated to Alzheimer's may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies targeting the immune system to slow or halt the progression of Alzheimer's disease.
How similar studies have performed: Previous research has shown promising results in understanding the immune system's role in Alzheimer's, suggesting that this approach could yield valuable insights.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Elyaman, Wassim — Columbia University Health Sciences
- Study coordinator: Elyaman, Wassim
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.